TakeAim Trial

Advertisement

cGxPJobs Banner

Curis Advances TakeAim CLL Trial with First Patients Dosed

LEXINGTON, Mass., July 30, 2026 Curis, Inc. has reached an important clinical milestone by successfully dosing the first five...

By cGxPwire Editor
August 1, 2026

Read More

Advertisement

cGxPJobs

Directory